Evidence map›Paper›PMID 26384083›Full record

ArticlePediatric hematology and oncology2015

Prolonged Complete Response in a Pediatric Patient With Primary Peripheral T-Cell Lymphoma of the Central Nervous System.

Haneen Shalabi, Anne Angiolillo, Gilbert Vezina, James L Rubenstein, Stefania Pittaluga, Mark Raffeld, Leigh Marcus

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric hematology and oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Primary peripheral T-cell central nervous system lymphoma.Surgical neurology international · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Haneen Shalabia Division of Pediatric Hematology and Oncology, Center for Cancer and Blood Disorders , Children's National Medical Center , Washington, DC , USA.
Anne Angiolilloa Division of Pediatric Hematology and Oncology, Center for Cancer and Blood Disorders , Children's National Medical Center , Washington, DC , USA.
Gilbert Vezinab Department of Radiology, Children's National Medical Center , Washington, DC , USA.
James L Rubensteinc Division of Hematology and Oncology , University of California, San Francisco , California , USA.
Stefania Pittalugad Laboratory of Pathology , National Institutes of Health , Bethesda , Maryland , USA.
Mark Raffeldd Laboratory of Pathology , National Institutes of Health , Bethesda , Maryland , USA.
Leigh Marcuse Food and Drug Administration , Silver Spring , Maryland , USA.
Center for Cancer and Blood Disorders · USNational Institutes of Health · USChildren's National · USUnited States Food and Drug Administration · USUniversity of California, San Francisco · US

Funding

Molecular Diagnostics Core LaboratoryZICBC011079 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI XI, LIQIANG · 2009 to 2025
$33.8M
The Role of Interleukin-4 (IL-4) in the Pathogenesis of Non-Hodgkin's LymphomaR01CA139083 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUBENSTEIN, JAMES LOUIS · 2009 to 2018
$3.4M
Targeted Therapies in CNS LymphomasR21CA184694 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUBENSTEIN, JAMES LOUIS · 2014 to 2015
$378k
NCI NIH HHS R01 CA139083NCI NIH HHS R21 CA184694
6 · The paper itself

Abstract

We describe a child with a 2-week history of progressive headaches, blurry vision, and intermittent vomiting. Magnetic resonance imaging (MRI) of the brain showed a deep left hemispheric lesion with extension into the corpus callosum. Histology and immunophenotyping of the lesion was consistent with peripheral T-cell lymphoma, not otherwise specified. Chemotherapy was initiated and a complete remission was achieved. This case illustrates that a chemotherapeutic regimen used in adults with central nervous system (CNS) lymphoma can achieve durable remissions in pediatric patients with peripheral T-cell lymphoma, not otherwise specified of the CNS.

Indexed as

Magnetic Resonance ImagingBrain NeoplasmsChildCorpus CallosumFemaleHumansLymphoma, T-Cell, PeripheralRadiographyRemission InductionCNS tumorsNHLtherapy

Identifiers

PMID26384083
PMCPMC4942274
OpenAlexW1900535054

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.